Title | Structured Chart Review: Assessment of a Structured Chart Review Methodology. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Siems, A, Banks, R, Holubkov, R, Meert, KL, Bauerfeld, C, Beyda, D, Berg, RA, Bulut, Y, Burd, RS, Carcillo, J, J Dean, M, Gradidge, E, Hall, MW, McQuillen, PS, Mourani, PM, Newth, CJL, Notterman, DA, Priestley, MA, Sapru, A, Wessel, DL, Yates, AR, Zuppa, AF, Pollack, MM |
Journal | Hosp Pediatr |
Volume | 10 |
Issue | 1 |
Pagination | 61-69 |
Date Published | 2020 Jan |
ISSN | 2154-1671 |
Keywords | Humans, Medical Audit, Medical Records, Morbidity, Mortality, Reproducibility of Results, Surveys and Questionnaires |
Abstract | <p><b>BACKGROUND AND OBJECTIVES: </b>Chart reviews are frequently used for research, care assessments, and quality improvement activities despite an absence of data on reliability and validity. We aim to describe a structured chart review methodology and to establish its validity and reliability.</p><p><b>METHODS: </b>A generalizable structured chart review methodology was designed to evaluate causes of morbidity or mortality and to identify potential therapeutic advances. The review process consisted of a 2-tiered approach with a primary review completed by a site physician and a short secondary review completed by a central physician. A total of 327 randomly selected cases of known mortality or new morbidities were reviewed. Validity was assessed by using postreview surveys with a Likert scale. Reliability was assessed by percent agreement and interrater reliability.</p><p><b>RESULTS: </b>The primary reviewers agreed or strongly agreed in 94.9% of reviews that the information to form a conclusion about pathophysiological processes and therapeutic advances could be adequately found. They agreed or strongly agreed in 93.2% of the reviews that conclusions were easy to make, and confidence in the process was 94.2%. Secondary reviewers made modifications to 36.6% of cases. Duplicate reviews ( = 41) revealed excellent percent agreement for the causes (80.5%-100%) and therapeutic advances (68.3%-100%). κ statistics were strong for the pathophysiological categories but weaker for the therapeutic categories.</p><p><b>CONCLUSIONS: </b>A structured chart review by knowledgeable primary reviewers, followed by a brief secondary review, can be valid and reliable.</p> |
DOI | 10.1542/hpeds.2019-0225 |
Alternate Journal | Hosp Pediatr |
PubMed ID | 31879317 |
PubMed Central ID | PMC6931034 |
Grant List | P2C HD047879 / HD / NICHD NIH HHS / United States UG1 HD083166 / HD / NICHD NIH HHS / United States U10 HD049981 / HD / NICHD NIH HHS / United States UG1 HD083170 / HD / NICHD NIH HHS / United States U01 HD049934 / HD / NICHD NIH HHS / United States U10 HD050096 / HD / NICHD NIH HHS / United States U10 HD063114 / HD / NICHD NIH HHS / United States UG1 HD050096 / HD / NICHD NIH HHS / United States U10 HD050012 / HD / NICHD NIH HHS / United States UG1 HD083171 / HD / NICHD NIH HHS / United States U10 HD049983 / HD / NICHD NIH HHS / United States RL1 HD107773 / HD / NICHD NIH HHS / United States U10 HD063108 / HD / NICHD NIH HHS / United States |